Patents by Inventor Frédérique Lantoine-Adam

Frédérique Lantoine-Adam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A DHA ESTER FOR PROPHYLACTIC AND/OR CURATIVE TREATMENT OF DREPANOCYTOSIS
    Publication number: 20150306056
    Abstract: The present invention relates to a docosahexaenoic acid ester including an alcohol selected from among the group made up of nicotinol, panthenol, inositol, isosorbide, and isosorbide mononitrate, or one of the pharmaceutically acceptable salts, enantiomers, diastereoisomers, or mixtures thereof, including racemic mixtures, for the use thereof as a drug for the prophylactic and/or curative treatment of drepanocytosis.
    Type: Application
    Filed: November 27, 2013
    Publication date: October 29, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Jean-Paul CAUBERE, Frédérique LANTOINE-ADAM
  • PANTHENYL DOCOSAHEXAENEOATE AND ITS USE FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES
    Publication number: 20150291507
    Abstract: The present invention relates to the docosahexaenoate panthenyl of the following formula: It also relates to a method for preparing same and to a pharmaceutical composition comprising same and to the use of same in the treatment or the prevention of cardiovascular diseases, in particular atrial fibrillation.
    Type: Application
    Filed: June 24, 2015
    Publication date: October 15, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Frédérique LANTOINE-ADAM, Robert LETIENNE, Elisabeth DUPONT-PASSELAIGUE
  • PANTHENYL DOCOSAHEXAENEOATE AND ITS USE FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES
    Publication number: 20130137768
    Abstract: The present invention relates to the docosahexaenoatepanthenyl of the following formula: It also relates to a method for preparing same and to a pharmaceutical composition comprising same and to the use of same in the treatment or the prevention of cardiovascular diseases, in particular atrial fibrillation.
    Type: Application
    Filed: August 11, 2011
    Publication date: May 30, 2013
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Frédérique Lantoine-Adam, Robert Letienne, Elisabeth Dupont-Passelaigue